The safety of the popular diabetes drug Avandia (rosiglitazone), manufactured by Glaxo, has been called into question by Food and Drug Administration (FDA) staff scientists and the drug was recently placed at risk for a massive recall.  The result of the vote by the FDA panel after a two-day meeting with the endocrinologic and metabolic […]